KFA
IBB icon

Kapstone Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Kapstone Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,102
Closed -$257K – 99
2023
Q3 		$257K Sell
2,102
-9
-0.4% -$1.15K 0.23% 77
2023
Q2 		$270K Sell
2,111
-16
-0.8% -$2.08K 0.22% 79
2023
Q1 		$284K Sell
2,127
-46
-2% -$6.02K 0.26% 74
2022
Q4 		$298K Buy
+2,173
New +$281K 0.27% 74

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kapstone Financial Advisors's IBB Position: Q4 2023 in Review

Kapstone Financial Advisors sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 2,102 shares — an estimated $257K sold.

Kapstone Financial Advisors first reported a position in IBB in Q4 2022 and held it in 4 quarters. The position peaked at $298K in Q4 2022. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • Kapstone Financial Advisors reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Kapstone Financial Advisors sold 2,102 iShares Biotechnology ETF shares in Q4 2023, an estimated $257K.
  • Kapstone Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2022 and held it in 4 quarters.
  • Kapstone Financial Advisors's iShares Biotechnology ETF position peaked at $298K in Q4 2022.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Kapstone Financial Advisors's 13F filing for Q4 2023, filed 5 Feb 2024.